HCPCS code J0475: Injection, baclofen, 10 mg billing guide

Key Takeaways

HCPCS code J0475 describes Injection, baclofen, 10 mg and is used for billing injectable baclofen administered in a clinical setting.

Bill one unit of J0475 per 10 mg of baclofen administered; verify the exact dose given to calculate units accurately.

J0475 has single-dose container status under CMS policy, making JW or JZ wastage modifier documentation mandatory when applicable.

Practice management software like Pabau supports structured drug billing workflows that reduce J0475 claim denials and documentation errors.

HCPCS code J0475 covers Injection, baclofen, 10 mg, billed under the Drugs Administered Other than Oral Method category of HCPCS Level II J-codes. In practice, most claim denials for this code come down to one of three mistakes: billing the wrong number of units, omitting a required wastage modifier, or submitting without the correct NDC cross-reference.

HCPCS code J0475: code description and clinical context

HCPCS code J0475 represents a single 10 mg dose of injectable baclofen, a skeletal muscle relaxant and antispastic agent. Claims management software that handles J-code billing must correctly identify the drug category and administration route before submitting. The Centers for Medicare and Medicaid Services (CMS) places J0475 within HCPCS Level II under the J-code classification, which covers drugs administered other than by the oral route.

Baclofen works by acting on GABA-B receptors in the spinal cord to reduce muscle spasticity. Clinically, it treats conditions including multiple sclerosis, spinal cord injury, and cerebral palsy. J0475 covers intrathecal baclofen delivered through a pump implanted during a procedure such as CPT 62350, then billed at scheduled maintenance refill visits. The pre-implant screening trial that determines pump candidacy uses a separate code, J0476, at a much smaller 50 mcg dose scale. Baclofen given by intramuscular or intravenous injection does not use either intrathecal code – it is billed under HCPCS code J0428 (Injection, intravenous or intramuscular baclofen, per 10 mg).

The code remains active in the 2026 HCPCS code set as maintained by CMS. Coders should also confirm annual HCPCS updates, since drug code descriptors and coverage policies can shift with each January update cycle.

Code properties at a glance

How to calculate billing units for J0475

One unit of HCPCS code J0475 equals 10 mg of baclofen administered. If a patient receives 20 mg, bill two units. For 40 mg, bill four units. The unit calculation is straightforward. However, billing errors occur when staff round up to the vial size instead of billing the dose actually given.

Baclofen for injection is commonly available in 10 mg/20 mL vials and 40 mg/20 mL vials. Typical clinical scenarios include:

• 10 mg administered: Bill 1 unit of J0475
• 20 mg administered: Bill 2 units of J0475
• 40 mg administered: Bill 4 units of J0475
• Dose less than 10 mg: Bill 1 unit (the minimum billable increment) and document the wastage

The patient record must reflect the exact dose given. As a result, payer audits for injectable drug codes focus heavily on dose-to-unit alignment.

The same per-unit logic applies to other single-dose injectable drugs, including HCPCS J7324 and HCPCS J9217, so billing teams managing several J-codes benefit from one consistent unit-calculation workflow. Practices that also bill wellness services can apply the same discipline to coaching CPT codes billed alongside clinical care.

JW and JZ modifier requirements for HCPCS code J0475

CMS has designated baclofen (J0475) as a drug supplied in single-dose containers. As a result, this single-dose status triggers mandatory wastage modifier reporting under the CMS JW/JZ Modifier Policy.

JW modifier (Drug Amount Discarded/Not Administered): Use when a portion of the drug from a single-dose container is discarded and not administered to the patient. Bill the administered units on one claim line and the discarded units on a separate claim line with the JW modifier. The JW line documents the waste without generating additional reimbursement for the discarded portion.

JZ modifier (Zero Drug Waste): Use when the entire contents of the single-dose container are administered with zero wastage. The JZ modifier effectively certifies that no drug was discarded. Failure to report either JW or JZ – when the code is on the single-dose container list – can result in claim rejection or audit exposure.

For example, administration-procedure codes carry similar wastage and modifier logic, such as CPT 96374 when billed on the same claim as an injectable drug code like J0475.

Documenting drug wastage accurately fits within the broader HIPAA-compliant documentation practices that support injectable drug billing. Keep the administered dose and discarded amount recorded in the clinical note, since payers may request supporting documentation during review.

Medicare fee schedule and reimbursement context for J0475

Medicare Part B covers injectable baclofen when the drug meets medical necessity requirements. J0475 reimbursement under the buy-and-bill model is generally set at the Average Sales Price (ASP) plus a percentage markup, following standard Part B drug payment rules. Because ASP-based rates are updated quarterly by CMS, specific dollar amounts change throughout the year.

For current verified reimbursement rates, use the CMS fee schedule tool and filter by HCPCS code J0475. This gives you the most up-to-date allowed amounts by MAC jurisdiction and setting.

Key reimbursement considerations for Medicare Part B billing of J0475:

• Medical necessity must be documented in the clinical record before submitting the claim
• The treating diagnosis code (ICD-10-CM) must support use of baclofen as clinically indicated
• Coverage may be subject to a Local Coverage Determination (LCD) from the applicable Medicare Administrative Contractor (MAC)
• Part B drug payment rates are updated quarterly – verify current rates before billing large volumes

Multi-specialty practices that also handle fertility treatment billing can apply the same fee-schedule discipline to IVF CPT codes, keeping reimbursement expectations current each quarter across every drug and procedure code on the books. Use the AAPC Codify HCPCS lookup to cross-check code status and payer-specific notes alongside the CMS data.

State Medicaid and commercial payer coverage

Coverage for HCPCS code J0475 varies across Medicaid programs and commercial payers. Indiana Medicaid (IHCP) moved J0475 from open fee pricing to maximum fee pricing effective July 1, 2025, per IHCP Bulletin BT2025158 – verify current IHCP rates directly with the Indiana Medicaid portal. California Medi-Cal covers injectable baclofen under its drug injection policies, with billing details outlined in the Medi-Cal provider manual.

Commercial payers including AmeriHealth Caritas use J-code conversion grids that cross-reference J0475 to the specific NDC and unit strength on the claim. Some commercial plans also require prior authorization for injectable baclofen. Confirm payer-specific billing instructions and authorization rules before submitting, as coverage criteria and modifier requirements can differ from Medicare policy.

Reduce injectable drug billing errors

Pabau's claims management tools help practices track administered doses, apply correct modifiers, and submit accurate J-code claims the first time. See how it works for your practice.

Book a demo

NDC cross-reference for HCPCS code J0475

Submitting HCPCS code J0475 to many payers requires including the National Drug Code (NDC) on the claim. The J0475 NDC number identifies the exact drug product, manufacturer, and package size, so it gives payers more detail than the J-code alone provides. According to NDCList.com, about 22 NDC codes currently map to HCPCS J0475.

When billing J0475 with an NDC, the claim must include:

• NDC qualifier (N4): Identifies the number as an NDC in the required format
• 11-digit NDC: The specific product identifier in 5-4-2 format
• NDC unit qualifier: Typically ML (milliliters) for injectable baclofen
• NDC quantity: The actual volume of drug administered from the vial

Payers such as AmeriHealth Caritas provide J-code-to-NDC conversion grids that list the NDC qualifier, strength, volume, and conversion factor for baclofen. Accurate IV therapy intake documentation should capture the exact vial lot number and NDC at the point of administration, making claim submission faster and more accurate. The PGM HCPCS lookup tool from PGM Billing provides a free searchable HCPCS database useful for cross-verifying NDC linkages against CMS data.

NDC-to-J0475 mapping workflow

Using automated billing workflows to capture NDC data at the point of care also removes manual data-entry errors between the administration record and the claim form.

J0475 vs. J0476 vs. J0428: Choosing the correct baclofen billing code

J0475, J0476, and J0428 all bill for baclofen, but each describes a different route, dose scale, and clinical purpose. Submitting the wrong code is a clinical documentation error, not just a billing error.

The dose scales are entirely different: J0475 bills in 10 mg increments for intrathecal maintenance dosing, while J0476 bills in 50 microgram increments for the pre-implant screening trial. Using J0475 for an intrathecal screening trial would overstate the unit count on the claim by orders of magnitude. Intramuscular or intravenous baclofen does not belong in this comparison at all – that route is billed under J0428. The IV therapy EMR software a practice uses must map each drug administration event to the correct HCPCS code based on route, delivery method, and dose rather than drug name alone.

Therefore, document the administration route and clinical purpose clearly in the note. Intrathecal maintenance dosing (J0475), an intrathecal screening trial (J0476), and intramuscular or intravenous administration (J0428) each require a different code, and auditors check the documented route against the code billed on the claim.

Complications tied to the implanted pump itself use separate codes entirely, such as ICD-10 Y83.6 or CPT 00620 – another reminder to document each element of the encounter precisely.

Claim submission workflow for J0475

A systematic claim submission process reduces first-pass denial rates for injectable drug codes. IV therapy clinic management platforms that integrate drug administration logging with billing reduce the manual steps between care delivery and claim submission.

Follow these steps for each J0475 claim:

1. Confirm diagnosis: Record the ICD-10-CM diagnosis code supporting medical necessity for baclofen (e.g. spasticity related to multiple sclerosis, spinal cord injury, or cerebral palsy).
2. Document the administered dose: Record exact milligrams administered in the clinical note. This becomes the basis for unit calculation.
3. Calculate billing units: Divide administered mg by 10 to get the J0475 unit count.
4. Record the NDC: Capture the 11-digit NDC from the vial label, volume administered in mL, and unit qualifier (ML).
5. Apply the wastage modifier: Add JZ if the full single-dose container was used; add JW on a separate line for any discarded portion.
6. Submit the claim: Include J0475 with units, NDC data block, wastage modifier, and the supporting ICD-10-CM code(s).
7. Review the remittance: Check the explanation of benefits for any line-level adjustments on the J0475 line, which often signals a unit or modifier discrepancy.

Following IV therapy best practices for drug documentation means less time spent on rework and fewer repeat audits from payers. Structured clinical workflows and practice compliance documentation create a defensible paper trail for every J0475 encounter.

Practices offering additional non-invasive treatments alongside injectable drug programs can standardize post-procedure guidance with templates such as JuVaShape aftercare instructions, keeping documentation consistent across every service line.

Conclusion

HCPCS code J0475 is a high-audit injectable drug code. Together, the single-dose container rules, NDC reporting requirements, and the J0475/J0476 distinction create several points where claims can fail. Getting it right requires accurate dose documentation at the point of care and a billing workflow that enforces modifier and NDC requirements before submission.

Pabau’s claims management software is built to support structured drug billing workflows, so injectable drug codes like J0475 get submitted with the right modifiers and NDC data the first time. To see how Pabau handles J-code claim workflows for your practice, book a demo.

Continue your research

Managing injectable drug administration records? Digital patient intake forms streamline pre-administration screening and capture structured clinical data that supports accurate drug billing.

Running a clinic with IV or injectable services? How to open an IV therapy clinic covers the operational and compliance foundations for injectable service delivery.

Need to understand broader HCPCS billing compliance? HIPAA compliance for medical offices outlines documentation requirements that apply across injectable drug billing encounters.

Frequently asked questions